Invesco Exchange-Traded Fund Trust - Invesco Dynamic Biotechnology & Genome ETF reported earnings results for the full year ended April 30, 2023. For the full year, the company reported revenue was USD 1.18 million. Net income was USD 23.92 million.
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Biotechnology & Genome ETF
Equities
PBE
US46137V7872
Investment Trusts
1st Jan change | Capi. | |
---|---|---|
+3.27% | 14.32B | |
+3.12% | 6.21B | |
+12.72% | 4.4B | |
+10.97% | 4.36B | |
-7.52% | 4B | |
+3.61% | 3.51B | |
+8.55% | 3.22B | |
+7.91% | 3.06B | |
-1.91% | 2.77B |